Evaluation of the Safety, Systemic Pharmacokinetics, and Tolerability of Single and Repeat Ocular Instillations of LE Ophthalmic Gel

Trial Profile

Evaluation of the Safety, Systemic Pharmacokinetics, and Tolerability of Single and Repeat Ocular Instillations of LE Ophthalmic Gel

Completed
Phase of Trial: Phase I

Latest Information Update: 19 May 2017

At a glance

  • Drugs Loteprednol etabonate (Primary)
  • Indications Allergic conjunctivitis; Keratoconjunctivitis sicca; Ocular inflammation; Ocular pain
  • Focus Pharmacokinetics
  • Sponsors Bausch & Lomb
  • Most Recent Events

    • 16 May 2017 Status changed from recruiting to completed.
    • 25 Apr 2017 Status changed from not yet recruiting to recruiting.
    • 07 Apr 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top